9:30am ET
Health and Healthcare
The Most Loved Biotechs of Big Hedge Funds
There were some interesting positions of hedge funds in biotech, long and short, from the Goldman Sachs Hedge Fund Trend Monitor.
Companies
Celgene
$108.24
▲ $0.00 (+0.00%) today
Markets open · 10:08am ET
CELG Coverage
Page 188:05am ET
Health and Healthcare
Short Sellers Start to Get Nervous on Biotech
The short interest data are out for the April 30 settlement date, and for most of the selected biotech stocks, short interest is down.
10:00am ET
Health and Healthcare
Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks
In a new report, Deutsche Bank acknowledges that while the industry has shown recent weakness, now may be just the right time to add biotech stocks.
8:50am ET
Health and Healthcare
Is Celgene Stumped on Its Portfolio?
Celgene released mixed first-quarter results before the markets opened Thursday and shares were down in early trading.
Chris Lange 3:05pm ET
Health and Healthcare
What to Expect From Celgene Earnings
ThinkstockCelgene Corp. (NASDAQ: CELG) is scheduled to release its first-quarter financial results before the markets open Thursday. Thomson Reuters has consensus estimates of $1.06 in earnings per share (EPS) on $2.11 billion…
Chris Lange 8:30am ET
Health and Healthcare
Short Sellers Become More Wary of Big Biotech
The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
2:00pm ET
Health and Healthcare
Can a Small New Stem Cell Pact Move the Needle for Celgene?
Celgene is one of the world's top biotech stocks now, and its market cap is nearly $100 billion. The company has made a new investment in a stem cell company in Australia.
Jon C. Ogg 8:35am ET
Health and Healthcare
Short Sellers Increase Their Bets Against Biotech Stocks
The March 31 short interest data have been compared with the March 13 figures, and for most of the selected biotech stocks, short interest has increased.
9:15am ET
Health and Healthcare
Major Biotech Is So-So for Short Sellers
The March 13 short interest data in top biotechs have been compared with the end of February figures, and across the board all the selected stocks have seen their short interest increase.
2:10pm ET
Health and Healthcare
How the Weaker Euro Is Impacting Biotech Earnings
Wells Fargo released a report Wednesday that considers the future of major biotech companies in relation to the weak euro.
9:15am ET
Health and Healthcare
Short Sellers Get More Aggressive on Big Biotech
24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with the mid-February figures. Across the board, all the selected stocks have seen…
8:35am ET
Health and Healthcare
The 5 Most Loved Biotech Stocks of Portfolio Managers
A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money managers love and are staying with.
9:25am ET
Health and Healthcare
Short Sellers Increase Bets Against Biotech as Shares Continue to Rise
The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
3:31pm ET
Health and Healthcare
Is Revlimid Becoming a Catch-All Cancer Drug?
Celgene has announced that the FDA expanded the existing indication for Revlimid in conjunction with dexamethasone.
Chris Lange 8:25am ET
Health and Healthcare
Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015
Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid pipelines and, most importantly, earnings.